Participations à des congrès et colloques internationaux (10)
7.
De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 98) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).8.
De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 72) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).9.
Kosa, A.-C., Ando, K., Lasri, H., Yilmaz, Z., Doeraene, E., López Gutiérrez, L., De Decker, R., De Fisenne, M.-A., Suain, V., Buée, L., Brion, J. P., & Leroy, K. (2021). Deletion of murine APP accelerates cognitive deficits in a murine model of amyloid and tau pathologies. (p. 88) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).10.
De Fisenne, M.-A., Ando, K., Yilmaz, Z., Mansour, S., Brion, J. P., & Leroy, K. (2017). Intraocular injection of fibrillary PHF-tau isolated from Alzheimer's disease brain : effect on tau pathology development in wild-type and tau transgenic mice. Abstract session presented at Eurotau(28 April 2017: Lille) Thèses et mémoires (1)
Divers (2)